A useful approach for activation of specific neuronal pathways using DREADDs and CAV-1 Cre
A nice proof-of-concept paper was just published in PLOS ONE
Combined Use of the Canine Adenovirus-2 and DREADD-Technology to Activate Specific Neural Pathways In Vivo
Here canine associated adenovirus (CAV) expressing Cre-recombinase was used to specifically express hM3Dq (AAV-DIO-hSyn-hM3Dq-mCherry) in VTA neurons projecting to the striatum. This paper is nice as it describes the technology in some detail.
I note a similar use of this approach was previously described by Carter et al (Nature, 2013).
My sense is that this technology will be broadly useful...
Combined Use of the Canine Adenovirus-2 and DREADD-Technology to Activate Specific Neural Pathways In Vivo
Here canine associated adenovirus (CAV) expressing Cre-recombinase was used to specifically express hM3Dq (AAV-DIO-hSyn-hM3Dq-mCherry) in VTA neurons projecting to the striatum. This paper is nice as it describes the technology in some detail.
I note a similar use of this approach was previously described by Carter et al (Nature, 2013).
My sense is that this technology will be broadly useful...
Is Cre-recombinase common both optogenetics and DREADDs?
ReplyDeleteYes. See Urban and Roth Ann Rev Pharmacol 2015
ReplyDelete